Remove Artificial Intelligence Remove Biotech Remove Machine Learning
article thumbnail

Qventus Latest Healthcare AI Startup To Raise Big

Crunchbase News

Healthcare startups using artificial intelligence have come out of the gate hot in the new year when it comes to fundraising. Qventus platform tries to address operational inefficiencies in both inpatient and outpatient settings using generative AI, machine learning and behavioural science.

article thumbnail

Healthcare And AI Is A Hot Combination For Startups

Crunchbase News

billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. The smash hit of the past year was Tempus AI , an artificial intelligence precision medicine company that went public in June.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 178
article thumbnail

MGX’s AI Role In The US Grows

Crunchbase News

It was reported MGX a $100 billion artificial intelligence-focused investment vehicle founded by sovereign wealth fund Mubadala and Abu Dhabi-based AI company G42 plans to contribute about $7 billion to the new Stargate Project. However, that is nothing new for the firm when it comes to large AI investments in the U.S.

article thumbnail

Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too

TechCrunch

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. “I hope it doesn’t sound corny, but we don’t have the luxury to move more slowly,” explained Immunai co-founder and CEO Noam Solomon in an interview.

article thumbnail

Genesis Therapeutics raises $52M A round for its AI-focused drug discovery mission

TechCrunch

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265
article thumbnail

Ultima Genomics claims $100 full genome sequencing after stealth $600M raise

TechCrunch

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. The third advance involves machine learning to accelerate the process of turning optical data (the CD-style scanning signal) into usable data.

Biotech 315